SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Keros Therapeutics, Inc. – KROS
Pomerantz LLP is investigating claims on behalf of investors of Keros Therapeutics, Inc. (“Keros” or the “Company”) (NASDAQ: KROS).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Keros and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here […]